Skip to main content

Research Repository

Advanced Search

Genome-wide DNA methylation profiling in rheumatoid arthritis identifies disease-associated methylation changes that are distinct to individual T- and B-lymphocyte populations.

Glossop, John R.; Emes, Richard; Nixon, Nicola B.; Haworth, Kim E.; Packham, Jon C.; Dawes, Peter T.; Fryer, Anthony A.; Mattey, Derek L.; Farrell, William E.

Authors

John R. Glossop

Richard Emes

Nicola B. Nixon

Kim E. Haworth

Jon C. Packham

Peter T. Dawes

Anthony A. Fryer

Derek L. Mattey

William E. Farrell



Abstract

Changes to the DNA methylome have been described in patients with rheumatoid arthritis (RA). In previous work, we reported genome-wide methylation differences in T-lymphocyte and B-lymphocyte populations from healthy individuals. Now, using HumanMethylation450 BeadChips to interrogate genome-wide DNA methylation, we have determined disease-associated methylation changes in blood-derived T- and B-lymphocyte populations from 12 female patients with seropositive established RA, relative to 12 matched healthy individuals. Array data were analyzed using NIMBL software and bisulfite pyrosequencing was used to validate array candidates. Genome-wide DNA methylation, determined by analysis of LINE-1 sequences, revealed higher methylation in B-lymphocytes compared with T-lymphocytes (P ? 0.01), which is consistent with our findings in healthy individuals. Moreover, loci-specific methylation differences that distinguished T-lymphocytes from B-lymphocytes in healthy individuals were also apparent in RA patients. However, disease-associated methylation differences were also identified in RA. In these cases, we identified 509 and 252 CpGs in RA-derived T- and B-lymphocytes, respectively, that showed significant changes in methylation compared with their cognate healthy counterparts. Moreover, this included a restricted set of 32 CpGs in T-lymphocytes and 20 CpGs in B-lymphocytes (representing 15 and 10 genes, respectively, and including two, MGMT and CCS, that were common to both cell types) that displayed more substantial changes in methylation. These changes, apparent as hyper- or hypo-methylation, were independently confirmed by pyrosequencing analysis. Validation by pyrosequencing also revealed additional sites in some candidate genes that also displayed altered methylation in RA. In this first study of genome-wide DNA methylation in individual T- and B-lymphocyte populations in RA patients, we report disease-associated methylation changes that are distinct to each cell type and which support a role for discrete epigenetic regulation in this disease.

Journal Article Type Article
Acceptance Date Jun 24, 2014
Online Publication Date Jul 7, 2014
Publication Date Jul 7, 2014
Deposit Date Apr 30, 2018
Print ISSN 1559-2294
Electronic ISSN 1559-2308
Publisher Taylor & Francis
Peer Reviewed Peer Reviewed
Volume 9
Issue 9
Pages 1228-1237
DOI https://doi.org/10.4161/epi.29718
Public URL https://nottingham-repository.worktribe.com/output/1098489
Publisher URL https://www.tandfonline.com/doi/abs/10.4161/epi.29718
Related Public URLs https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169015/
PMID 25147922


Downloadable Citations